$VRAX News
Last published 1w ago
- 1w agoVRAXVirax Biolabs Appoints Three Distributors for ImmuneSelect Research Products in Mainland ChinaPR NewswireThree new distributor agreements build on initial China sales and extend the Company's distributor-led commercial strategyLONDON, Oct. 29, 2026 /PRNewswire/ -- Virax Biolabs Group Limited (NASDAQ:VRAX)
- 3mo agoVRAXFollowVirax Biolabs' CEO James Foster Provides Shareholder Update Following Fiscal 2026 Annual Report and Fosun Diagnostics Commercial Supply AgreementPR NewswireVirax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), a biotechnology company focused on immune response detection, T cell immune...
- 4mo agoVRAXVirax Biolabs Group Limited Announces Closing of Exercise of Preferred Investment Options for $3.3 Million Gross ProceedsPR NewswireVirax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX) today closed its previously announced exercise of certain outstanding preferred ...
- 4mo agoVRAXENVXSPCXThese Companies Just Dropped Major Growth CatalystsGlobeNewswireDENVER, July 10, 2026 (GLOBE NEWSWIRE) -- (247marketnews.com) -- A wave of corporate announcements, from international distribution agreements and manufacturing leadership appointments to expanding government
- 4mo agoVRAXVirax Biolabs Group Limited Announces Exercise of Preferred Investment Options for $3.3 Million Gross ProceedsPR NewswireVirax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX) announced today that it has entered into a definitive agreement for the...
- 4mo agoVRAXVirax Biolabs Signs Multi-Country Commercial Supply Agreement with Fosun DiagnosticsPR NewswireVirax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company") today announced that its wholly owned subsidiary, Virax Biolabs (UK) Limited,...
- 4mo agoVRAXVirax Biolabs Group Limited Announces 1-for-25 Share ConsolidationPR NewswireVirax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company") today announced that the board of directors of the Company approved a share...
- 5mo agoVRAXVirax Biolabs Reports Positive Early Clinical Data for ViraxImmune™ in Long COVID and Related Post-Acute Infection SyndromesPR NewswireVirax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company") today reported positive early pilot performance data for ViraxImmune™, its...
- 7mo agoVRAXVirax Biolabs' CEO James Foster Outlines Strategic Priorities and Near-Term Milestones in Letter to ShareholdersPR NewswireVirax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on immunology research and...
- 7mo agoVRAXVirax Biolabs Achieves ISO Certifications, Laying Foundation for Regulated IVD Development and U.S. Clinical ValidationPR NewswireVirax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company") today announced that Virax Biolabs (UK) Limited, its wholly owned subsidiary,...
- 11mo agoVRAXVirax Biolabs Group Limited Announces Closing of $5 Million Private PlacementPR NewswireVirax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company dedicated to the advancement of immunology ...
- 11mo agoVRAXVirax Biolabs Group Limited Announces $5 Million Private PlacementPR NewswireVirax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company dedicated to the advancement of immunology ...
- 11mo agoVRAXVirax Biolabs' CEO James Foster Outlines Clinical Progress and 2026 Priorities in Latest Annual Letter to ShareholdersPR NewswireVirax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company dedicated to the advancement of immunology ...
- 1y agoVRAXVirax Biolabs Completes UK Clinical Recruitment and Reports Constructive FDA Feedback for ViraxImmune™ Study Evaluating T Cell Dysfunction in Post-Acute Infection SyndromesPR NewswireVirax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune...
- 1y agoVRAXVirax Biolabs Partners with Emory University on ViraxImmune™ Clinical Studies; Readies for FDA Pre-Submission Meeting in Early SeptemberPR NewswireVirax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on immune response detection and...
- 1y agoVRAXVirax Biolabs Appoints Iain Miller, PhD as Independent Director to Accelerate Commercial StrategyPR NewswireVirax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company focused on the detection of immune...
- 1y agoVRAXVirax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price DeficiencyPR NewswireVirax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune...
- 1y agoVRAXVirax Biolabs Enrolls First Patients in Clinical Study Assessing T cell Dysfunction in Post-acute Infection SyndromesPR NewswireVirax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune...
- 1y agoVRAXVirax Biolabs Presents Data on T-Cell Dysfunction in Post-acute Infection Syndromes at the 19th World Immune Regulation MeetingPR NewswireVirax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company focused on the detection of immune...
- 1y agoVRAXVirax Biolabs to Present at 19th World Immune Regulation MeetingPR NewswireVirax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company focused on the detection of immune...
- 1y agoVRAXVirax Biolabs Believes Technology Aligns with United States Department of Health and Human Services' Transparency Priority on Vaccine EfficacyPR NewswireVirax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company") believes that its technology aligns with the United States Department of Health ...
- 1y agoCOSMVRAXCosmos Health Signs Expanded Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Saudi Arabia, the UAE, Qatar, and KuwaitACCESS NewswireCHICAGO, IL / ACCESS Newswire / January 23, 2025 / Cosmos Health Inc. , a diversified, vertically integrated global healthcare group engaged in
- 1y agoCOSMVRAXCosmos Health Secures Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Greece and Cyprus, with Additional Rights in Select European and GCC CountriesACCESS NewswireCHICAGO, IL / ACCESSWIRE / January 13, 2025 / Cosmos Health Inc. , a diversified, vertically integrated global healthcare group engaged in innovative
- 1y agoVRAXVirax Biolabs' CEO James Foster Issues Letter to ShareholdersPR NewswireVirax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune...
- 1y agoVRAXVirax Biolabs Announces Agreement with Tebubio to Expand Distribution of ImmuneSelect Across the European Union, Norway, and SwitzerlandPR NewswireVirax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune...
- 2y agoVRAXVirax Biolabs Announces Distribution Agreement with Europa Biosite to Commercialize ImmuneSelect in the United Kingdom and IrelandPR NewswireVirax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune...
- 2y agoVRAXCOSMVirax Biolabs Announces Extension of Existing Exclusive Distribution Agreement to Market Mpox (formerly Monkeypox) Virus Real-Time PCR Detection Kits with Cosmos Health Inc.PR NewswireVirax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune...
- 2y agoCOSMVRAXCosmos Health Secures Exclusivity Agreement with Virax Biolabs to Distribute mpox PCR Kits across the GCC, including the UAE, Saudi Arabia, Bahrain, Kuwait, Oman, and QatarACCESS NewswireCHICAGO, IL / ACCESSWIRE / September 16, 2024 / Cosmos Health Inc. , a diversified, vertically integrated global healthcare group engaged in innovative
- 2y agoVRAXVirax Biolabs Presents at H.C. Wainwright's 26th Annual Global Investment ConferencePR NewswireVirax Biolabs ("Virax" or the "Company") (NASDAQ: VRAX), an innovative biotechnology company focused on the detection of immune responses and...
- 2y agoVRAXVirax Biolabs to Participate at 7th European Congress of ImmunologyPR NewswireVirax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company focused on the detection of immune...
- 2y agoVRAXVirax Biolabs Announces Distribution Agreement to Commercialize Mpox (formerly Monkeypox) Virus RT-PCR Detection Kits in Europe and the Middle EastPR NewswireVirax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune...
- 2y agoVRAXVirax Biolabs Group Limited Announces Closing of $5 Million Registered Direct Offering of Ordinary SharesPR NewswireVirax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company focused on the detection of immune...
- 2y agoVRAXVirax Biolabs Group Limited Announces $5 Million Registered Direct Offering of Ordinary SharesPR NewswireVirax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), an innovative biotechnology company focused on the detection of immune...
- 2y agoCOSMVRAXCosmos Health Holds EU Distribution Rights for Virax Biolabs' Mpox (formerly Monkeypox) Virus Real-Time PCR Detection KitsACCESS NewswireCHICAGO, IL / ACCESSWIRE / August 21, 2024 / Cosmos Health Inc. , a diversified, vertically integrated global healthcare group engaged in innovative
- 2y agoVRAXVirax Biolabs Launches Portfolio of Immune Profiling Solutions Evaluating Adaptive Immunity in Post-Viral Syndromes at ESCMID Global 2024PR NewswireVirax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune...
- 2y agoVRAXVirax Biolabs to Participate at ESCMID Global 2024PR NewswireVirax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune...
- 2y agoVRAXVirax Biolabs Announces Receipt of NASDAQ Notification Letter Regarding Minimum Bid Price DeficiencyPR NewswireVirax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune...
- 2y agoVRAXVirax Biolabs Forges Strategic Research Collaboration with University of Manchester and the Northern Care Alliance Foundation Trust to Enhance Understanding of Immune Responses in COVID PatientsPR NewswireVirax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative biotechnology company focused on the detection of immune...
- 2y agoVRAXVirax Biolabs' CEO James Foster Issues Letter to ShareholdersPR NewswireVirax Biolabs Group Limited ("Virax" or the "Company") (Nasdaq: VRAX), today announced that Mr. James Foster, Chief Executive Officer of Virax, has...
- 2y agoVRAXVirax Biolabs Group Limited Announces 1-for-10 Share ConsolidationPR NewswireVirax Biolabs Group Limited (NASDAQ: VRAX) ("Virax" or the "Company"), an innovative diagnostics company focused on the detection of immune responses ...
- 3y agoVRAXVirax Biolabs Group Announces Early-Access Program Launch of Research Use Only ViraxImmune Product and Hosts WebinarPR NewswireLONDON, Sept. 12, 2023 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (NASDAQ:VRAX), an innovative diagnostics company focused on the detection of immune responses and diagnosis of
- 3y agoVRAXVirax Biolabs Group Appoints Dr. Nigel McCracken as Chief Operating Officer to Oversee Growth MomentumPR NewswireLONDON, Sept. 1, 2023 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (NASDAQ:VRAX), an innovative diagnostics company focused on the detection of immune responses and diagnosis of
- 3y agoVRAXNasdaq Approves 180-Day Extension for Virax Biolabs Group to Meet Minimum $1 BidPR NewswireLONDON, Aug. 3, 2023 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (NASDAQ:VRAX), an innovative diagnostics company focused on the detection of immune responses and diagnosis of
- 3y agoVRAXVirax Biolabs Group Continues Growth and Expansion with the Addition of Research and Laboratory FacilitiesPR NewswireLONDON and DUBAI, UAE, July 18, 2023 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (NASDAQ:VRAX), an innovative diagnostics company focused on the detection of immune responses
- 3y agoVRAXVirax Biolabs' CEO James Foster Issues Letter to ShareholdersPR NewswireLONDON and DUBAI, UAE , June 14, 2023 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (NASDAQ:VRAX), an innovative diagnostics company focused on the detection of immune responses
- 3y agoVRAXVirax Biolabs Group Announces Establishment of Regional Headquarters at Dubai Science ParkPR NewswireLONDON and DUBAI, UAE, May 4, 2023 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (NASDAQ:VRAX), an innovative diagnostics company focused on the detection of immune responses to
- 3y agoVRAXVirax Biolabs Group Limited Has Entered into an Agreement for the Distribution of Marburg Virus PCR Testing KitsPR NewswireLONDON, April 19, 2023 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (NASDAQ:VRAX), an innovative biotech company focused on the detection of immune responses to and diagnosis of
- 3y agoVRAXVirax Biolabs Group Limited Announces Closing of $4 Million Private Placement Priced At-The-Market Under Nasdaq RulesPR NewswireLONDON, March 10, 2023 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (NASDAQ:VRAX), an innovative biotechnology company focused on the prevention, detection, and diagnosis of
- 3y agoVRAXVirax Biolabs Group Limited Announces $4 Million Private Placement Priced At-The-Market Under Nasdaq RulesPR NewswireLONDON, March 8, 2023 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (NASDAQ:VRAX), an innovative biotechnology company focused on the prevention, detection, and diagnosis of viral
- 3y agoVRAXVirax Biolabs Group Limited Introduces Avian Influenza A Virus Real-Time PCR Test KitPR NewswireLONDON, March 7, 2023 /PRNewswire/ -- Virax Biolabs Group Limited ("Virax" or the "Company") (NASDAQ:VRAX), an innovative diagnostics company focused on the prevention, detection, and diagnosis of viral